Member Info for LTbeliever

In any case, as I said we don't know if the SP will break above 0.25, or pullback below 0.20, in the (likely) absence of an RNS; but I don't think whatever we write here affects these big SP movements, so if it's an upwards breakout then it's very likely that someone knows something; we will see in 17 hours or so.

JamYday, as you say it is possible that "Potential partners may look at the data and decide they want Nuformix to fund a Phase 1a safety study themselves before they buy it"; but it is also possible that, if the potential benefits of NPX2 are so good, Pharma A will decide to "take out" NPX2 now at a lower price and and out of competitor Pharma B's hands, rather than wait 1 year, see NPX2 results fly and see NFX sign with Pharma B. Is this implausible?

Nobody here knows what's really going on behind the scenes; some try to PnD, some call every single rise a PnD w/o really being certain that this time is different (or Not!); after a 20% rise on Friday, Monday will indicate if this rally has legs (for whatever reasons in the absence of an RNS), or whether profit taking will take place; as said many times, only insiders know what's going on and if someone is building a position for the RNS we (almost all of us) are expecting, then this is being (or will be) reflected in incremental SP rises. If the SP rises, some will say "we told you so, RNS is coming", if it drops due to profit taking, others will say " we said it was a PnD"; so, just be patient until the RNS drops; if people want to trade in and out, let them do so, liquidity is good for all as it allows smaller spreads. DYOR

Talks about a 12 month clinical study needed; so, not too long for potential partners and cash resources.

https://www.lse.co.uk/media/NFX/dr-dan-gooding-nuformix-increasingly-confident-us-regulators-will-grant-nxp002-orphan-drug-status-tu55q59g5zh9m7o.html

Sellers got out at sub-0.20, some may have made a small profit if they had bought in at 0.16+; others maybe got fed up and sold out, never to come back; I think this is clear; some may buy back in if there's a pull back.

But the Buyers? Are they in to make -hopefully - a 5-10% profit (remember the 3-5% each way spread, going in and out), or are they in for something bigger? IMO, as time goes by, and if the SP holds above 0.20, people will decide to stay in and maybe gradually add up to their positions. DYOR

FWIW, let's see if they are right and there's more fuel in this lift off.

https://www.britishbulls.com/SignalPage.aspx?lang=en&Ticker=NFX.L#google_vignette

Big_K, has Zoltar spoken about the date of the RNS??? :))

Just imagine if/when a deal is struck (before the RNS); how many people will know about it, outside NFX? Employees of the Big Pharma, lawyers of NFX and the big pharma etc.

Welcome back Big_K; all we need now for take-off is for FFXS to take the plunge :)))

I have a feeling that SRB kits' sales will be the pleasant surprise; Bob did mention in March's presentation that someone in Saudi Arabia had asked for as many kits as there were available; so, if they have sorted the production issues out, using a more cost-efficient process, then there is great potential.

The news next month will be important IMO as it'll ideally show that cashflow has begun; if this indeed happens, the new investors might refrain from selling "into strength" and hopefully hold onto their Placing shares @0.025. And we may also get news about the mineralisation studies of Layer 21? Is 5-6 weeks sufficient for first indications?

I agree that all it takes is 1 deal, for whatever amount, as it'd a) validate NPX002's commercial potential b) "fuel" NFX to continue towards more lucrative deals whilst further developing NPX2; it might even allow some cash for NPX4's development.

What's the downside though, in the next few weeks i.e of no news? Co is funded to mid-2027 as a minimum, so IMO the risk is from the overall market dropping (given the AI froth etc); this however will make pharma, a defensive sector, more attractive to rotation plays. IMO.

Some nice upwards movement!

Tnx Soup, so I stand corrected. Not accused yet of PnD, so that'a positive :)

Small but steady volumes, it seems like we will get the AFS next week.

Soup, actually no - this is from last year's "We remain focused on generating data and initiating, and further developing, discussions with potential partners that will support our efforts to secure out-license deals on NXP002".

Now they don't mention INITIATING etc; GLOBAL is new.

PSniffer, if that's the case i.e. "this outfit is on its knees", why did you express your goal to buy in at 0.15 just a few hours ago, and sell at 0.20? Surely, you are better off NOT buying in at any price. And "big dogs" work/collaborate with hundreds of small players like NFX, they don't go around buying all of them, or their IP, or waiting for them to go bust; they know at it's far better, business wise, to hedge their bets by working with as many as possible on multiple remedies/drugs etc because of competition, time to market, cost to market etc. GL to genuine holders, DYOR

Thanks UQ; I guess the optimists among us will agree with your "if pre-clinical data flows are positive over the next 4-6 months the partners will probably not wait to complete all the mechanistic and fibrosis assessments and move to a deal." This also aligns with Dan's early statement that a deal could happen even BEFORE the additional studies produce new data. So hopefully, good news in summertime?

Thanks UQ, so the game changing licensing deal 'd occur in next few months - given that we are already 2 months since the Placing, and the initiation (some time later) of the additional studies, would the outcome come sooner than "6+ months" that you mentioned below?

Maybe if you reduced spamming the BB with the same posts, people would be able to focus more and see the small positives, rather than just ignoring everything, good and bad? :)